2 Penny Stocks Swinging on Drug Data

BPTH stock is pacing for its best day in years

Apr 3, 2018 at 9:57 AM
    facebook X logo linkedin


    Bio-Path Holdings Inc (NASDAQ:BPTH) has shot 50.1% higher this morning to trade at $2.67 -- on track for its biggest one-day percentage gain since September 2013 -- after the company reported upbeat mid-stage trial data for its cancer drug, prexigebersen, when used in combination with low-dose chemotherapy. The therapy is being studied to possibly treat those with acute myeloid leukemia.

    With today's massive gain, the shares are up 38.5% year-to-date, but are running out of steam near their 200-day moving average -- a trendline that hasn't been conquered on a daily closing basis since July 2016. The penny stock has flown under the radar of analysts, too, with just one brokerage firm following BPTH stock, though they've issued a "strong buy" rating on the shares.

    On the flip side, shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) have plummeted 16.4% to trade at $2.95. Pressuring the stock is news the company's kidney disease drug, fostamatinib, failed in a mid-stage study treating patients with IgA nephropathy.

    It's been a choppy six months for RIGL stock, which has been bouncing between support in the $3.20-$3.50 range and resistance in the $4.50-$4.70 neighborhood since October. And while the shares have breached the lower end of this range today, they are pacing for their first daily close below their 200-day moving average since late September.

    It looks like options traders have been bracing for more losses, too. The April 2.50 put is home to peak open interest of 13,176 contracts, and data from Trade-Alert points to significant buy-to-open activity here in early March.
     

    Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

    This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

    On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

    Start targeting gains like the ones our subscribers have seen recently, including:

    213.3% GAIN on AutoNation calls
    100.0% GAIN on Monster Beverage calls
    100.4% GAIN on Walgreens Boots Alliance puts
    100.4% GAIN on ON Semiconductor calls
    257.7% GAIN on Dell calls

    101.0% GAIN on Apollo Global Management calls
    103.6% GAIN on JP Morgan  Chase calls
    105.3% GAIN on DraftKings calls
    101.3% GAIN on Airbnb calls
    203.0% GAIN on Shopify calls
    102.0% GAIN on Cboe Global Markets calls
    100.9% GAIN on Boeing calls
    102.1% GAIN on Microsoft puts
    102.3% GAIN on First Solar calls
    101.5% GAIN on PulteGroup calls
    101.0% GAIN on Apple calls
    209.4% GAIN on NXP Semiconductors calls
    100.8% GAIN on Uber Technologies calls
    100.4% GAIN on Academy Sports and Outdoors puts
    102.2% GAIN on Trade Desk calls
    100.8% GAIN on DoorDash calls
    100.0% GAIN on Camping World Holdings puts
    100.0% GAIN on Cboe Global Markets calls
    100.2% GAIN on C3.ai calls
    238.5% GAIN on Oracle calls

     
     
     


     
     

    Rainmaker Ads CGI